Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
143 hedge funds and large institutions have $1.47B invested in Epizyme, Inc in 2020 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 52 increasing their positions, 47 reducing their positions, and 22 closing their positions.
888% more call options, than puts
Call options by funds: $47.9M | Put options by funds: $4.84M
41% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 22
11% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 47
5% more funds holding
Funds holding: 136 → 143 (+7)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
35% less capital invested
Capital invested by funds: $2.25B → $1.47B (-$781M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RM
RP Management
New York
|
+$53.7M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$36.7M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$29.7M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$9.82M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$6.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$34.1M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$21.5M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$12.8M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$7.19M |
| 5 |
Morgan Stanley
New York
|
-$6.33M |
EPZM Hedge Fund Activity: Q1 2020 in Review
143 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q1 2020, worth a combined $1.47B — down 35% from $2.25B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new EPZM positions and 22 closed out — a net gain of 9 holders — while 52 added to existing stakes and 47 trimmed.
The largest buyer was RP Management, adding an estimated $53.7M. The largest seller was Opaleye Management, exiting entirely with an estimated $34.1M sold.
- 143 institutional investors held Epizyme, Inc (EPZM) as of Q1 2020, up from 136 in Q4 2019.
- Funds reported $1.47B of Epizyme, Inc stock for Q1 2020, down 35% quarter-over-quarter.
- 31 funds opened new Epizyme, Inc positions in Q1 2020 and 22 closed out, a net change of +9 holders.
- The largest Epizyme, Inc buyer in Q1 2020 was RP Management, an estimated $53.7M added.
- The largest Epizyme, Inc seller in Q1 2020 was Opaleye Management, an estimated $34.1M sold.
Based on aggregated 13F filings for Q1 2020.